Gunnar Brobert

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

BMJ open

International journal of clinical practice

Expert opinion on drug safety

Drugs - real world outcomes

Bayer Sverige AB

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bayer Sverige AB Jan 14 2013

Sweden

Director Epidemiology :: Epidemilogy

Publications

Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Annemarie Voss, Elisabeth Smits, Karin M A Swart, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ron M C Herings, Cristina Rebordosa, Ulrike Haug
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands. Drugs - real world outcomes (2023)
Antonio Gonzalez Perez, Yanina Balabanova, María Eugenia Sáez, Gunnar Brobert, Luis Alberto García-Rodríguez
Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom. Clinical epidemiology 14 (2022)
Pareen Vora, Henry Morgan Stewart, Beth Russell, Alex Asiimwe, Gunnar Brobert
Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States. International journal of clinical practice 2022 (2022)
Ana Ruigómez, Gunnar Brobert, Pareen Vora, Luis Alberto García-Rodríguez
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network. Pharmacoepidemiology and drug safety 30 (2) (2020)
Luis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, Ana Ruigómez, Cristina Rebordosa, Irene D Bezemer, Ron M C Herings, Saad Shakir, Alison Evans, Miranda Davies, Kiliana Suzart-Woischnik, Pareen Vora, Yanina Balabanova, Montse Soriano Gabarró, Gunnar Brobert
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert opinion on drug safety 19 (11) (2020)

Gunnar Brobert.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gunnar Brobert